Xbio.Bk

XBIO.BK has a price-to-book ratio of 4.49 and a price-to-tangible-book ratio of 4.49, indicating that the market is valuing the company's book value at a premium. The company's liquidity position is characterized by a current ratio of 0.93, suggesting that it has less current assets than current liabilities, which could pose a liquidity risk. The company's debt-to-equity ratio of 1.11 indicates that it is financed by a combination of debt and equity, with a slight lean towards debt financing.

In terms of profitability, XBIO.BK reported a net income of -468,974,140.0 THB, indicating a significant loss for the period. The return on equity of -2.165% and return on assets of -0.7697% further highlight the company's unprofitable performance, with both metrics well below the industry median. The operating income of -429,624,690.0 THB and a gross profit of 52,931,540.0 THB suggest that the company is struggling to cover its operating expenses and is not generating sufficient gross profit to support its operations.

XBIO.BK's revenue of 129,545,190.0 THB is derived from its banking and investment services, but the company's financial snapshot does not provide specific details on revenue concentration by segment or geography. The absence of detailed segment data limits the ability to assess the company's exposure to different markets or product lines.

The company's growth trajectory is currently negative, with a net income loss of -468,974,140.0 THB and a free cash flow of -416,127,070.0 THB. The operating cash flow of -75,291,730.0 THB and capital expenditure of -3,591,300.0 THB indicate that the company is not generating positive cash flows from operations and is not investing in new capital assets. The company's revenue history does not show a clear upward trend, and the outlook for the current fiscal year is uncertain.

The risk assessment for XBIO.BK highlights a medium liquidity risk, with a current ratio of 0.93 and a negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company's financial position is further complicated by a negative operating income and a high debt-to-equity ratio, which could increase the risk of insolvency.

Recent events and filings for XBIO.BK do not provide specific details on recent developments, but the company's financial performance suggests that it may be facing operational challenges. The absence of recent transcripts or filings limits the ability to assess the company's strategic direction and management's response to its financial difficulties.